Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

VTGN Relative to the S&P 500

VTGN Relative to the Sector

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the VistaGen Therapeutics Inc. (NASD:VTGN) seasonal charts above shows that a Buy Date of December 3 and a Sell Date of March 13 has resulted in a geometric average return of 10.18% above the benchmark rate of the S&P 500 Total Return Index over the past 13 years. This seasonal timeframe has shown positive results compared to the benchmark in 9 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 13 years by an average of 56.6% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Vistagen Therapeutics Inc is a biotechnology firm. The company is?neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.

To download VTGN seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: VTGN